| 0.35 0 (0%) | 08-13 20:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.96 | 1-year : | 1.31 |
| Resists | First : | 0.82 | Second : | 1.12 |
| Pivot price | 0.34 | |||
| Supports | First : | 0.32 | Second : | 0.27 |
| MAs | MA(5) : | 0.34 | MA(20) : | 0.34 |
| MA(100) : | 0.34 | MA(250) : | 4.62 |
|
| MACD | MACD : | -0.1  |
Signal : | -0.1 |
| %K %D | K(14,3) : | 3.1 | D(3) : | 3.1 |
| RSI | RSI(14): 23.6 | |||
| 52-week | High : | 20 | Low : | 0.32 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ DNMR ] has closed Bollinger Bands are 100% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 145 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 1.13 - 1.14 | 1.14 - 1.14 |
| Low: | 0.32 - 0.32 | 0.32 - 0.32 |
| Close: | 0.35 - 0.35 | 0.35 - 0.35 |
Danimer Scientific, Inc., a performance polymer company, develops, produces, and provides bioplastic replacements for traditional petroleum-based plastics. It produces polyhydroxyalkanoate, a biodegradable plastic feedstock alternative used in a range of plastic applications, including films, straws, food containers, and other things under the Nodax brand name; polylactic acid-based resins for coating disposable paper cups; and other biopolymers. The company offers its products for biopolymers, including additives, aqueous coatings, fibers, filaments, films, thermoforming, and injection-molded articles. It also markets its products to consumer packaging brand owners, converters, and manufacturers in the plastics industry. Danimer Scientific, Inc. was founded in 2004 and is headquartered in Bainbridge, Georgia.
Thu, 17 Apr 2025
Bidding Procedure Approved for Danimer Scientific, Inc. - MarketScreener
Tue, 25 Mar 2025
Case Summary: Danimer Scientific Chapter 11 - Bondoro
Tue, 31 Dec 2024
Danimer Scientific Faces NYSE Delisting as Market Cap Falls Below $15M Threshold, Plans OTCQX Move - Stock Titan
Wed, 18 Dec 2024
DNMR Stock Touches 52-Week Low at $3.62 Amid Market Challenges - Investing.com
Sat, 14 Dec 2024
Danimer Scientific announces executive retention agreements - Investing.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
OTC
|
|
|
Sector:
Basic Materials
|
|
|
Industry:
Chemicals - Specialty
|
|
| Shares Out | 3 (M) |
| Shares Float | 3 (M) |
| Held by Insiders | 9.2 (%) |
| Held by Institutions | 6.3 (%) |
| Shares Short | 494 (K) |
| Shares Short P.Month | 450 (K) |
| EPS | -40.41 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 70.08 |
| Profit Margin | -297.2 % |
| Operating Margin | -217.4 % |
| Return on Assets (ttm) | -8 % |
| Return on Equity (ttm) | -43.2 % |
| Qtrly Rev. Growth | -21.3 % |
| Gross Profit (p.s.) | -7.93 |
| Sales Per Share | 12.39 |
| EBITDA (p.s.) | -18.93 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -62 (M) |
| Levered Free Cash Flow | -26 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0.02 |
| Price to Cash Flow | -0.02 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|